Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

People

Sasha
Rosenthal-Larrea

Partner, Corporate

srosenthal-larrea@cravath.com
  • New York+1-212-474-1967
    • E-mail
    • Twitter
    • Facebook
    • LinkedIn
  • PDF
  • Vcard
  • Overview
  • Credentials
  • Featured Work
  • News & Insights

Maya Rosenthal-Larrea (Sasha) focuses her practice on advising clients on their most significant intellectual property issues, including with respect to complex licensing and collaborations, patent and copyright licensing strategy, software and artificial intelligence. She also handles the intellectual property, data privacy and broader technology aspects of major corporate transactions. Additionally, she regularly advises public company clients with respect to governance, public disclosure and other corporate matters.

Ms. Rosenthal-Larrea’s clients have included ADT, Ahold Delhaize, Amazon, AmerisourceBergen, Aon, Bacardi, BAE Systems, BDT, Biogen, Brookfield, Centrica, Disney, IBM, Illumina, Johnson & Johnson, KION Group, Lindsay Goldberg, OMERS Private Equity, Oshkosh, Qualcomm, RELX, Robinhood, Unilever and Valvoline.

Ms. Rosenthal-Larrea represented Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement.

Ms. Rosenthal-Larrea has been repeatedly recognized for her corporate work. She was named to the 2023 list of “Notable Women in Law” by Crain’s New York Business and recognized as a “Rising Star” by Law360 in 2019 and by New York Law Journal in 2020. Ms. Rosenthal-Larrea has also been recognized by The Legal 500 US, IAM Patent 1000, IFLR1000, Lawdragon and The Legal 500 Latin America.

Ms. Rosenthal-Larrea was born in Washington, D.C. She received an A.B. from Brown University and a J.D. from Columbia Law School.

Ms. Rosenthal-Larrea joined Cravath in 2011 and was elected a partner in 2018. She worked in the Firm’s London office from 2014 to 2016 and is currently based in the Firm’s New York office.

Ms. Rosenthal-Larrea represented Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement.

Ms. Rosenthal-Larrea has been repeatedly recognized for her corporate work. She was named to the 2023 list of “Notable Women in Law” by Crain’s New York Business and recognized as a “Rising Star” by Law360 in 2019 and by New York Law Journal in 2020. Ms. Rosenthal-Larrea has also been recognized by The Legal 500 US, IAM Patent 1000, IFLR1000, Lawdragon and The Legal 500 Latin America.

Ms. Rosenthal-Larrea was born in Washington, D.C. She received an A.B. from Brown University and a J.D. from Columbia Law School.

Ms. Rosenthal-Larrea joined Cravath in 2011 and was elected a partner in 2018. She worked in the Firm’s London office from 2014 to 2016 and is currently based in the Firm’s New York office.

Education

  • J.D., 2010, Columbia Law School
    Harlan Fiske Stone Scholar
  • A.B., 2007, Brown University

Admitted In

  • New York

Professional Affiliations

American Intellectual Property Law Association (AIPLA)

Rankings

Crain’s New York Business

  • Notable Women in Law (2023)

Intellectual Asset Management

  • IAM Patent 1000: The World’s Leading Patent Practitioners (2024, 2023)

IFLR1000 - US (2025-2021)

Law360

  • Rising Star (2019)

Lawdragon

  • 500 Leading Global Cyber Lawyers (2025, 2024)
  • 500 Leading Global IP Lawyers (2025)

The Legal 500 US

  • Fintech (2025, 2024)
  • Technology Transactions (2025, 2024)

The Legal 500 Latin America

  • Latin America: International Firms (2021)

New York Law Journal

  • Rising Star (2020)

Deals & Cases

November 18, 2025

Axalta’s $25 Billion Merger of Equals with AkzoNobel

On November 18, 2025, Axalta Coating Systems Ltd. (“Axalta”) and Akzo Nobel N.V. announced that they have entered into a definitive agreement to combine in an all‑stock merger of equals, creating a premier global coatings company with an enterprise value of approximately $25 billion. Cravath is representing Axalta in connection with the transaction.

Deals & Cases

November 17, 2025

Johnson & Johnson’s $3.05 Billion Acquisition of Halda Therapeutics OpCo, Inc.

On November 17, 2025, Johnson & Johnson announced it has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc., a clinical‑stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera (RIPTACTM) platform to develop oral, targeted therapies for multiple types of solid tumors, including prostate cancer, for $3.05 billion in cash. Cravath is representing Johnson & Johnson in connection with the transaction.

Deals & Cases

November 03, 2025

Kenvue’s $48.7 Billion Acquisition by Kimberly‑Clark

On November 3, 2025, Kenvue Inc. (“Kenvue”), a global consumer health leader, and Kimberly‑Clark Corporation (“Kimberly‑Clark”), a global personal care leader, announced an agreement under which Kimberly‑Clark will acquire all of the outstanding shares of Kenvue common stock in a cash and stock transaction that values Kenvue at an enterprise value of approximately $48.7 billion, based on the closing price of Kimberly‑Clark common stock on October 31, 2025. Under the terms of the agreement, which has been unanimously approved by each company’s Board of Directors, Kenvue shareholders will receive $3.50 per share in cash as well as 0.14625 Kimberly‑Clark shares for each Kenvue share held at closing. Upon closing of the transaction, current Kenvue shareholders are expected to own approximately 46% and current Kimberly‑Clark shareholders are expected to own approximately 54% of the combined company on a fully diluted basis. Cravath is representing Kenvue in connection with the transaction.

Deals & Cases

October 27, 2025

Alliance Laundry Holdings Inc.’s IPO

Cravath represented Alliance Laundry Holdings Inc. in connection with its $950.29 million initial public offering of common stock. Alliance Laundry Holdings, an affiliate of BDT & MSD Partners, LLC, is the world’s largest designer and manufacturer of commercial laundry systems, serving a diverse range of global markets. The transaction closed on October 10, 2025.

Deals & Cases

October 15, 2025

Royal Caribbean Cruises Ltd.’s $1.5 Billion Registered Senior Notes Offering

Cravath represented the underwriters in connection with the $1.5 billion registered senior notes offering of Royal Caribbean Cruises Ltd., a global cruise company. The transaction closed on October 1, 2025.

Activities

October 13, 2025

Sasha Rosenthal-Larrea Hosts Roundtable at World IP Review’s AI and IP Summit USA 2025

On October 9, 2025, Cravath partner Sasha Rosenthal-Larrea participated in the World IP Review’s AI and IP Summit USA in New York. The one-day conference brought together private practice, in-house teams and AI pioneers to unlock AI’s potential and drive innovation in IP strategies, featuring sessions on streamlining legal workflows, navigating evolving regulations, building ethical frameworks and developing future-facing legal skill sets. Sasha hosted a roundtable discussion entitled “Where to draw the line between collaboration and protection? Open-source innovation in the AI era.”

Activities

October 08, 2025

Sasha Rosenthal-Larrea Speaks at PLI’s Understanding the Intellectual Property License 2025 Program

On October 7, 2025, Cravath partner Sasha Rosenthal-Larrea participated in “Understanding the Intellectual Property License 2025,” a program presented by the Practising Law Institute in New York. Sasha spoke on a panel entitled “Antitrust Issues in Licensing,” which discussed antitrust standards, horizontal and vertical licenses, restrictions in IP licenses and differences between the application of U.S. and EU antitrust law to IP licenses.

Publications

September 22, 2025

Cravath Data Privacy and Security Review: H1 2025

On September 18, 2025, Cravath published the fifth edition of its Cravath Data Privacy and Security Review newsletter. The Review provides an overview of recent U.S. state and federal legislative and regulatory developments, alongside U.S. and global enforcement trends and takeaways, in data privacy and cybersecurity for the first six months of 2025. It first presents an update on emerging and existing privacy and security legislation at the federal level, including amendments to the Children’s Online Privacy Protection Rule, then highlights notable legislative developments at the state level across the country. This edition also explores the heightened focus on cybersecurity- and privacy‑related enforcement at federal agencies, including the Federal Trade Commission, Securities and Exchange Commission and Department of Justice, and provides global enforcement updates from the European Union and China.

Publications

August 11, 2025

Cravath Venture Capital & Growth Equity Insights: 2025 Mid‑Year Market Update

On August 11, 2025, Cravath published the latest edition of its Venture Capital & Growth Equity Insights newsletter, which has been redesigned to provide greater insight into global venture capital and related activity during the first half of 2025 and outlook for the rest of the year. Key takeaways from this edition include:

Activities

May 02, 2025

Cravath Partners Named to Lawdragon’s 2025 List of Leading Global Cyber Lawyers

On May 2, 2025, Cravath partners David J. Kappos, John D. Buretta, Noah Joshua Phillips, Sasha Rosenthal‑Larrea, Evan Norris, Michael L. Arnold and Kimberley S. Drexler were named to Lawdragon’s list of “500 Leading Global Cyber Lawyers” in recognition of their work advising clients on incident response and preparation, corporate governance and disclosure matters, investigations and regulatory enforcement, and transactional and competition matters related to data privacy and cybersecurity. The list recognizes “world leaders in privacy, data, security, incident response, and the deals and lawsuits that revolve around all things Cyber.”

Maya Rosenthal-Larrea (Sasha) focuses her practice on advising clients on their most significant intellectual property issues, including with respect to complex licensing and collaborations, patent and copyright licensing strategy, software and artificial intelligence. She also handles the intellectual property, data privacy and broader technology aspects of major corporate transactions. Additionally, she regularly advises public company clients with respect to governance, public disclosure and other corporate matters.

Ms. Rosenthal-Larrea’s clients have included ADT, Ahold Delhaize, Amazon, AmerisourceBergen, Aon, Bacardi, BAE Systems, BDT, Biogen, Brookfield, Centrica, Disney, IBM, Illumina, Johnson & Johnson, KION Group, Lindsay Goldberg, OMERS Private Equity, Oshkosh, Qualcomm, RELX, Robinhood, Unilever and Valvoline.

Ms. Rosenthal-Larrea represented Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement.

Ms. Rosenthal-Larrea has been repeatedly recognized for her corporate work. She was named to the 2023 list of “Notable Women in Law” by Crain’s New York Business and recognized as a “Rising Star” by Law360 in 2019 and by New York Law Journal in 2020. Ms. Rosenthal-Larrea has also been recognized by The Legal 500 US, IAM Patent 1000, IFLR1000, Lawdragon and The Legal 500 Latin America.

Ms. Rosenthal-Larrea was born in Washington, D.C. She received an A.B. from Brown University and a J.D. from Columbia Law School.

Ms. Rosenthal-Larrea joined Cravath in 2011 and was elected a partner in 2018. She worked in the Firm’s London office from 2014 to 2016 and is currently based in the Firm’s New York office.

Ms. Rosenthal-Larrea represented Qualcomm in the commercial terms of its settlement of global litigation with Apple, including a global six‑year patent license agreement and a multiyear chipset supply agreement.

Ms. Rosenthal-Larrea has been repeatedly recognized for her corporate work. She was named to the 2023 list of “Notable Women in Law” by Crain’s New York Business and recognized as a “Rising Star” by Law360 in 2019 and by New York Law Journal in 2020. Ms. Rosenthal-Larrea has also been recognized by The Legal 500 US, IAM Patent 1000, IFLR1000, Lawdragon and The Legal 500 Latin America.

Ms. Rosenthal-Larrea was born in Washington, D.C. She received an A.B. from Brown University and a J.D. from Columbia Law School.

Ms. Rosenthal-Larrea joined Cravath in 2011 and was elected a partner in 2018. She worked in the Firm’s London office from 2014 to 2016 and is currently based in the Firm’s New York office.

Education

  • J.D., 2010, Columbia Law School
    Harlan Fiske Stone Scholar
  • A.B., 2007, Brown University

Admitted In

  • New York

Professional Affiliations

American Intellectual Property Law Association (AIPLA)

Rankings

Crain’s New York Business

  • Notable Women in Law (2023)

Intellectual Asset Management

  • IAM Patent 1000: The World’s Leading Patent Practitioners (2024, 2023)

IFLR1000 - US (2025-2021)

Law360

  • Rising Star (2019)

Lawdragon

  • 500 Leading Global Cyber Lawyers (2025, 2024)
  • 500 Leading Global IP Lawyers (2025)

The Legal 500 US

  • Fintech (2025, 2024)
  • Technology Transactions (2025, 2024)

The Legal 500 Latin America

  • Latin America: International Firms (2021)

New York Law Journal

  • Rising Star (2020)

Deals & Cases

November 18, 2025

Axalta’s $25 Billion Merger of Equals with AkzoNobel

On November 18, 2025, Axalta Coating Systems Ltd. (“Axalta”) and Akzo Nobel N.V. announced that they have entered into a definitive agreement to combine in an all‑stock merger of equals, creating a premier global coatings company with an enterprise value of approximately $25 billion. Cravath is representing Axalta in connection with the transaction.

Deals & Cases

November 17, 2025

Johnson & Johnson’s $3.05 Billion Acquisition of Halda Therapeutics OpCo, Inc.

On November 17, 2025, Johnson & Johnson announced it has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc., a clinical‑stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera (RIPTACTM) platform to develop oral, targeted therapies for multiple types of solid tumors, including prostate cancer, for $3.05 billion in cash. Cravath is representing Johnson & Johnson in connection with the transaction.

Deals & Cases

November 03, 2025

Kenvue’s $48.7 Billion Acquisition by Kimberly‑Clark

On November 3, 2025, Kenvue Inc. (“Kenvue”), a global consumer health leader, and Kimberly‑Clark Corporation (“Kimberly‑Clark”), a global personal care leader, announced an agreement under which Kimberly‑Clark will acquire all of the outstanding shares of Kenvue common stock in a cash and stock transaction that values Kenvue at an enterprise value of approximately $48.7 billion, based on the closing price of Kimberly‑Clark common stock on October 31, 2025. Under the terms of the agreement, which has been unanimously approved by each company’s Board of Directors, Kenvue shareholders will receive $3.50 per share in cash as well as 0.14625 Kimberly‑Clark shares for each Kenvue share held at closing. Upon closing of the transaction, current Kenvue shareholders are expected to own approximately 46% and current Kimberly‑Clark shareholders are expected to own approximately 54% of the combined company on a fully diluted basis. Cravath is representing Kenvue in connection with the transaction.

Deals & Cases

October 27, 2025

Alliance Laundry Holdings Inc.’s IPO

Cravath represented Alliance Laundry Holdings Inc. in connection with its $950.29 million initial public offering of common stock. Alliance Laundry Holdings, an affiliate of BDT & MSD Partners, LLC, is the world’s largest designer and manufacturer of commercial laundry systems, serving a diverse range of global markets. The transaction closed on October 10, 2025.

Deals & Cases

October 15, 2025

Royal Caribbean Cruises Ltd.’s $1.5 Billion Registered Senior Notes Offering

Cravath represented the underwriters in connection with the $1.5 billion registered senior notes offering of Royal Caribbean Cruises Ltd., a global cruise company. The transaction closed on October 1, 2025.

Activities

October 13, 2025

Sasha Rosenthal-Larrea Hosts Roundtable at World IP Review’s AI and IP Summit USA 2025

On October 9, 2025, Cravath partner Sasha Rosenthal-Larrea participated in the World IP Review’s AI and IP Summit USA in New York. The one-day conference brought together private practice, in-house teams and AI pioneers to unlock AI’s potential and drive innovation in IP strategies, featuring sessions on streamlining legal workflows, navigating evolving regulations, building ethical frameworks and developing future-facing legal skill sets. Sasha hosted a roundtable discussion entitled “Where to draw the line between collaboration and protection? Open-source innovation in the AI era.”

Activities

October 08, 2025

Sasha Rosenthal-Larrea Speaks at PLI’s Understanding the Intellectual Property License 2025 Program

On October 7, 2025, Cravath partner Sasha Rosenthal-Larrea participated in “Understanding the Intellectual Property License 2025,” a program presented by the Practising Law Institute in New York. Sasha spoke on a panel entitled “Antitrust Issues in Licensing,” which discussed antitrust standards, horizontal and vertical licenses, restrictions in IP licenses and differences between the application of U.S. and EU antitrust law to IP licenses.

Publications

September 22, 2025

Cravath Data Privacy and Security Review: H1 2025

On September 18, 2025, Cravath published the fifth edition of its Cravath Data Privacy and Security Review newsletter. The Review provides an overview of recent U.S. state and federal legislative and regulatory developments, alongside U.S. and global enforcement trends and takeaways, in data privacy and cybersecurity for the first six months of 2025. It first presents an update on emerging and existing privacy and security legislation at the federal level, including amendments to the Children’s Online Privacy Protection Rule, then highlights notable legislative developments at the state level across the country. This edition also explores the heightened focus on cybersecurity- and privacy‑related enforcement at federal agencies, including the Federal Trade Commission, Securities and Exchange Commission and Department of Justice, and provides global enforcement updates from the European Union and China.

Publications

August 11, 2025

Cravath Venture Capital & Growth Equity Insights: 2025 Mid‑Year Market Update

On August 11, 2025, Cravath published the latest edition of its Venture Capital & Growth Equity Insights newsletter, which has been redesigned to provide greater insight into global venture capital and related activity during the first half of 2025 and outlook for the rest of the year. Key takeaways from this edition include:

Activities

May 02, 2025

Cravath Partners Named to Lawdragon’s 2025 List of Leading Global Cyber Lawyers

On May 2, 2025, Cravath partners David J. Kappos, John D. Buretta, Noah Joshua Phillips, Sasha Rosenthal‑Larrea, Evan Norris, Michael L. Arnold and Kimberley S. Drexler were named to Lawdragon’s list of “500 Leading Global Cyber Lawyers” in recognition of their work advising clients on incident response and preparation, corporate governance and disclosure matters, investigations and regulatory enforcement, and transactional and competition matters related to data privacy and cybersecurity. The list recognizes “world leaders in privacy, data, security, incident response, and the deals and lawsuits that revolve around all things Cyber.”

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

Cravath, Swaine & Moore LLP Logo
  • CONTACT US
  • OUR STORY
  • ALUMNI PORTAL
  • DISCLAIMERS & NOTICES

Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.